{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:42:16Z","timestamp":1794465736463,"version":"4.9.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["B-9428"],"award-info":[{"award-number":["B-9428"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences","award":["RIGLD 1017"],"award-info":[{"award-number":["RIGLD 1017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammation plays a critical role in the promotion of hepatocyte damage and liver fibrosis. In recent years the protective role of <jats:italic>Akkermansia muciniphila<\/jats:italic>, a next-generation beneficial microbe, has been suggested for metabolic and inflammatory disorders. In this study, we aimed to evaluate the effects of live and pasteurized <jats:italic>A. muciniphila<\/jats:italic> and its extra cellular vesicles (EVs) on inflammatory markers involved in liver fibrosis in a mouse model of a high-fat diet (HFD)\/carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>)-induced liver injury. Firstly, the responses of hepatic stellate cells (HSCs) to live and pasteurized <jats:italic>A. muciniphila<\/jats:italic> and its EVs were examined in the quiescent and LPS-activated LX-2 cells. Next, the anti-inflammatory effects of different forms of <jats:italic>A. muciniphila<\/jats:italic> were examined in the mouse model of HFD\/CCl<jats:sub>4<\/jats:sub>-induced liver injury. The gene expression of various inflammatory markers was evaluated in liver, colon, and white adipose tissues. The cytokine secretion in the liver and white adipose tissues was also measured by ELISA. The results showed that administration of live and pasteurized <jats:italic>A. muciniphila<\/jats:italic> and its EVs leads to amelioration in HSCs activation. Based on data obtained from the histopathological analysis, an improvement in gut health was observed through enhancing the epithelium and mucosal layer thickness and strengthening the intestinal integrity in all treatments. Moreover, live <jats:italic>A. muciniphila<\/jats:italic> and its EVs had inhibitory effects on liver inflammation and hepatocytes damage. In addition, the tissue cytokine production and inflammatory gene expression levels revealed that live <jats:italic>A. muciniphila<\/jats:italic> and its EVs had more pronounced anti-inflammatory effects on liver and adipose tissues. Furthermore, EVs had better effects on the modulation of gene expression related to TLRs, PPARs, and immune response in the liver. In conclusion, the present results showed that oral administration of <jats:italic>A. muciniphila<\/jats:italic> and its derivatives for four weeks could enhance the intestinal integrity and anti-inflammatory responses of the colon, adipose, and liver tissues and subsequently prevent liver injury in HFD\/CCL<jats:sub>4<\/jats:sub> mice.<\/jats:p>","DOI":"10.1038\/s41598-022-06414-1","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T11:16:32Z","timestamp":1644837392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["The anti-inflammatory effects of Akkermansia muciniphila and its derivates in HFD\/CCL4-induced murine model of liver injury"],"prefix":"10.1038","volume":"12","author":[{"given":"Shahrbanoo Keshavarz Azizi","family":"Raftar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ashrafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Abdollahiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Yadegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzam","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arfa","family":"Moshiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7288-8112","authenticated-orcid":false,"given":"Seyed Davar","family":"Siadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9027-4560","authenticated-orcid":false,"given":"Mohammad Reza","family":"Zali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"6414_CR1","doi-asserted-by":"crossref","unstructured":"Seto, W.-K. & Mandell, M. S. Chronic liver disease: Global perspectives and future challenges to delivering quality health care. Plos one 16, e0243607 (2021).","DOI":"10.1371\/journal.pone.0243607"},{"key":"6414_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter, T. G. & Rinella, M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology 158, 1851\u20131864 (2020).","journal-title":"Gastroenterology"},{"key":"6414_CR3","doi-asserted-by":"crossref","unstructured":"Wang, S., Toy, M., Hang Pham, T. T. & So, S. Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the US, 2010\u20132019. PloS one 15, e0239393 (2020).","DOI":"10.1371\/journal.pone.0239393"},{"key":"6414_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/cells9010024","volume":"9","author":"O Khomich","year":"2020","unstructured":"Khomich, O., Ivanov, A. V. & Bartosch, B. Metabolic hallmarks of hepatic stellate cells in liver fibrosis. Cells 9, 24 (2020).","journal-title":"Cells"},{"key":"6414_CR5","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00109-019-01831-8","volume":"97","author":"M Kong","year":"2019","unstructured":"Kong, M. et al. Ablation of serum response factor in hepatic stellate cells attenuates liver fibrosis. J. Mol. Med. 97, 1521\u20131533 (2019).","journal-title":"J. Mol. Med."},{"key":"6414_CR6","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby, E. & Juge, N. Introduction to the human gut microbiota. Biochem. J. 474, 1823\u20131836 (2017).","journal-title":"Biochem. J."},{"key":"6414_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1152\/physiol.00005.2020","volume":"35","author":"L Jiang","year":"2020","unstructured":"Jiang, L. & Schnabl, B. Gut microbiota in liver disease: What do we know and what do we not know?. Physiology 35, 261\u2013274 (2020).","journal-title":"Physiology"},{"key":"6414_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1053\/j.gastro.2020.10.056","volume":"160","author":"C Acharya","year":"2021","unstructured":"Acharya, C. & Bajaj, J. S. Chronic liver diseases and the microbiome\u2014translating our knowledge of gut microbiota to management of chronic liver disease. Gastroenterology 160, 556\u2013572 (2021).","journal-title":"Gastroenterology"},{"key":"6414_CR9","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3389\/fmicb.2017.01804","volume":"8","author":"W Wu","year":"2017","unstructured":"Wu, W. et al. Protective effect of Akkermansia muciniphila against immune-mediated liver injury in a mouse model. Front. Microbiol. 8, 1804 (2017).","journal-title":"Front. Microbiol."},{"key":"6414_CR10","doi-asserted-by":"crossref","unstructured":"Derrien, M., Vaughan, E. E., Plugge, C. M. & de Vos, W. M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54, 1469\u20131476 (2004).","DOI":"10.1099\/ijs.0.02873-0"},{"key":"6414_CR11","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1128\/AEM.04050-14","volume":"81","author":"J Reunanen","year":"2015","unstructured":"Reunanen, J. et al. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Appl. Environ. Microbiol. 81, 3655\u20133662 (2015).","journal-title":"Appl. Environ. Microbiol."},{"key":"6414_CR12","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/1751-7915.13410","volume":"12","author":"T Zhang","year":"2019","unstructured":"Zhang, T., Li, Q., Cheng, L., Buch, H. & Zhang, F. Akkermansia muciniphila is a promising probiotic. Microb. Biotechnol. 12, 1109\u20131125 (2019).","journal-title":"Microb. Biotechnol."},{"key":"6414_CR13","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1038\/emm.2017.282","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot, C. et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp. Mol. Med. 50, e450\u2013e450 (2018).","journal-title":"Exp. Mol. Med."},{"key":"6414_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nm.4236","volume":"23","author":"H Plovier","year":"2017","unstructured":"Plovier, H. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23, 107\u2013113 (2017).","journal-title":"Nat. Med."},{"key":"6414_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12911-020-01312-w","volume":"20","author":"H Dehghanbanadaki","year":"2020","unstructured":"Dehghanbanadaki, H. et al. Global scientific output trend for Akkermansia muciniphila research: a bibliometric and scientometric analysis. BMC Med. Inform. Decis. Mak. 20, 1\u201312 (2020).","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"6414_CR16","doi-asserted-by":"crossref","unstructured":"Roshanravan, N. et al. A comprehensive systematic review of the effectiveness of Akkermansia muciniphila, a member of the gut microbiome, for the management of obesity and associated metabolic disorders. Arch. Physiol. Biochem., 1\u201311 (2021).","DOI":"10.1080\/13813455.2021.1871760"},{"key":"6414_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-021-01709-w","volume":"20","author":"F Ashrafian","year":"2021","unstructured":"Ashrafian, F. et al. Extracellular vesicles and pasteurized cells derived from Akkermansia muciniphila protect against high-fat induced obesity in mice. Microb. Cell Fact. 20, 1\u201317 (2021).","journal-title":"Microb. Cell Fact."},{"key":"6414_CR18","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nrmicro3480","volume":"13","author":"L Brown","year":"2015","unstructured":"Brown, L., Wolf, J. M., Prados-Rosales, R. & Casadevall, A. Through the wall: Extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat. Rev. Microbiol. 13, 620\u2013630 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"6414_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373\u2013383 (2013).","journal-title":"J. Cell Biol."},{"key":"6414_CR20","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesic. 4, 27066 (2015).","journal-title":"J. Extracell. Vesic."},{"key":"6414_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrmicro3525","volume":"13","author":"C Schwechheimer","year":"2015","unstructured":"Schwechheimer, C. & Kuehn, M. J. Outer-membrane vesicles from Gram-negative bacteria: Biogenesis and functions. Nat. Rev. Microbiol. 13, 605\u2013619 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"6414_CR22","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1042\/BST20180114","volume":"46","author":"R Stentz","year":"2018","unstructured":"Stentz, R., Carvalho, A. L., Jones, E. J. & Carding, S. R. Fantastic voyage: The journey of intestinal microbiota-derived microvesicles through the body. Biochem. Soc. Trans. 46, 1021\u20131027 (2018).","journal-title":"Biochem. Soc. Trans."},{"key":"6414_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2478\/s11756-019-00229-8","volume":"74","author":"B Jafari","year":"2019","unstructured":"Jafari, B., Nejad, R. A. K., Vaziri, F. & Siadat, S. D. Evaluation of the effects of extracellular vesicles derived from Faecalibacterium prausnitzii on lung cancer cell line. Biologia 74, 889\u2013898 (2019).","journal-title":"Biologia"},{"key":"6414_CR24","doi-asserted-by":"crossref","unstructured":"Rabiei, N. et al. Induction effects of Faecalibacterium prausnitzii and its extracellular vesicles on toll-like receptor signaling pathway gene expression and cytokine level in human intestinal epithelial cells. Cytokine 121, 154718 (2019).","DOI":"10.1016\/j.cyto.2019.05.005"},{"key":"6414_CR25","unstructured":"Raftar, S. K. A. et al. The Anti-fibrotic Effects of Heat-Killed Akkermansia muciniphila MucT on Liver Fibrosis Markers and Activation of Hepatic Stellate Cells. Probiot. Antimicrob. Prot., 1\u201312 (2021)."},{"key":"6414_CR26","doi-asserted-by":"crossref","unstructured":"Kang, C.-s. et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PloS one 8, e76520 (2013).","DOI":"10.1371\/journal.pone.0076520"},{"key":"6414_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/1440-1681.12102","volume":"40","author":"N Kubota","year":"2013","unstructured":"Kubota, N. et al. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice. Clin. Exp. Pharmacol. Physiol. 40, 422\u2013430 (2013).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"6414_CR28","doi-asserted-by":"publisher","first-page":"9464","DOI":"10.3390\/ijms21249464","volume":"21","author":"JE Kim","year":"2020","unstructured":"Kim, J. E. et al. Molecular characterization of constipation disease as novel phenotypes in CRISPR-Cas9-generated leptin knockout mice with obesity. Int. J. Mol. Sci. 21, 9464 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"6414_CR29","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/08941939.2019.1571129","volume":"33","author":"RD Shelby","year":"2020","unstructured":"Shelby, R. D. et al. Development of a standardized scoring system to assess a murine model of Clostridium difficile colitis. J. Invest. Surg. 33, 887\u2013895 (2020).","journal-title":"J. Invest. Surg."},{"key":"6414_CR30","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1053\/j.gastro.2008.09.002","volume":"135","author":"X Chen","year":"2008","unstructured":"Chen, X. et al. A mouse model of Clostridium difficile\u2013associated disease. Gastroenterology 135, 1984\u20131992 (2008).","journal-title":"Gastroenterology"},{"key":"6414_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-13451-8","volume":"7","author":"\u00c1 Anzai","year":"2017","unstructured":"Anzai, \u00c1. et al. Impaired branched-chain amino acid metabolism may underlie the nonalcoholic fatty liver disease-like pathology of neonatal testosterone-treated female rats. Sci. Rep. 7, 1\u201312 (2017).","journal-title":"Sci. Rep."},{"key":"6414_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/liv.13584","volume":"38","author":"DE Kleiner","year":"2018","unstructured":"Kleiner, D. E. Histopathological challenges in suspected drug-induced liver injury. Liver Int. 38, 198\u2013209 (2018).","journal-title":"Liver Int."},{"key":"6414_CR33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman, Z. D. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J. Hepatol. 47, 598\u2013607 (2007).","journal-title":"J. Hepatol."},{"key":"6414_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4254\/wjh.v10.i1.1","volume":"10","author":"JA Del Campo","year":"2018","unstructured":"Del Campo, J. A., Gallego, P. & Grande, L. Role of inflammatory response in liver diseases: Therapeutic strategies. World J. Hepatol. 10, 1 (2018).","journal-title":"World J. Hepatol."},{"key":"6414_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.aohep.2019.04.006","volume":"18","author":"SM Duarte","year":"2019","unstructured":"Duarte, S. M., Stefano, J. T. & Oliveira, C. P. Microbiota and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis (NAFLD\/NASH). Ann. Hepatol. 18, 416\u2013421 (2019).","journal-title":"Ann. Hepatol."},{"key":"6414_CR36","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.3748\/wjg.v18.i21.2609","volume":"18","author":"Y Ilan","year":"2012","unstructured":"Ilan, Y. Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis. World J. Gastroenterol.: WJG 18, 2609 (2012).","journal-title":"World J. Gastroenterol.: WJG"},{"key":"6414_CR37","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3389\/fmicb.2019.02155","volume":"10","author":"F Ashrafian","year":"2019","unstructured":"Ashrafian, F. et al. Akkermansia muciniphila-derived extracellular vesicles as a mucosal delivery vector for amelioration of obesity in mice. Front. Microbiol. 10, 2155 (2019).","journal-title":"Front. Microbiol."},{"key":"6414_CR38","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","volume":"67","author":"C Grander","year":"2018","unstructured":"Grander, C. et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut 67, 891\u2013901 (2018).","journal-title":"Gut"},{"key":"6414_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep34605","volume":"6","author":"H Nishizawa","year":"2016","unstructured":"Nishizawa, H. et al. IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. Sci. Rep. 6, 1\u201311 (2016).","journal-title":"Sci. Rep."},{"key":"6414_CR40","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.1210\/jc.2012-3290","volume":"98","author":"ML Hribal","year":"2013","unstructured":"Hribal, M. L. et al. Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 98, E304\u2013E308 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"6414_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tem.2009.01.002","volume":"20","author":"SB Wheatcroft","year":"2009","unstructured":"Wheatcroft, S. B. & Kearney, M. T. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and-2: Implications for metabolic homeostasis. Trends Endocrinol. Metab. 20, 153\u2013162 (2009).","journal-title":"Trends Endocrinol. Metab."},{"key":"6414_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mrrev.2016.08.007","volume":"772","author":"A Kasprzak","year":"2017","unstructured":"Kasprzak, A., Kwasniewski, W., Adamek, A. & Gozdzicka-Jozefiak, A. Insulin-like growth factor (IGF) axis in cancerogenesis. Mut. Res.\/Rev. Mut. Res. 772, 78\u2013104 (2017).","journal-title":"Mut. Res.\/Rev. Mut. Res."},{"key":"6414_CR43","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3390\/ijms18071447","volume":"18","author":"Y Takahashi","year":"2017","unstructured":"Takahashi, Y. The role of growth hormone and insulin-like growth factor-I in the liver. Int. J. Mol. Sci. 18, 1447 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"6414_CR44","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel, O. & Tacke, F. Liver macrophages in tissue homeostasis and disease. Nat. Rev. Immunol. 17, 306\u2013321 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"6414_CR45","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.tem.2018.08.003","volume":"29","author":"J Cai","year":"2018","unstructured":"Cai, J., Zhang, X.-J. & Li, H. Role of innate immune signaling in non-alcoholic fatty liver disease. Trends Endocrinol. Metab. 29, 712\u2013722 (2018).","journal-title":"Trends Endocrinol. Metab."},{"key":"6414_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4161\/adip.22929","volume":"2","author":"Y Nagai","year":"2013","unstructured":"Nagai, Y., Watanabe, Y. & Takatsu, K. The TLR family protein RP105\/MD-1 complex: A new player in obesity and adipose tissue inflammation. Adipocyte 2, 61\u201366 (2013).","journal-title":"Adipocyte"},{"key":"6414_CR47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/imm.13251","volume":"161","author":"H Yan","year":"2020","unstructured":"Yan, H. et al. TLR5 activation in hepatocytes alleviates the functional suppression of intrahepatic CD8+ T cells. Immunology 161, 325\u2013344 (2020).","journal-title":"Immunology"},{"key":"6414_CR48","doi-asserted-by":"publisher","first-page":"E874","DOI":"10.1073\/pnas.1521359113","volume":"113","author":"CM Brackett","year":"2016","unstructured":"Brackett, C. M. et al. Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis. Proc. Natl. Acad. Sci. 113, E874\u2013E883 (2016).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"6414_CR49","doi-asserted-by":"crossref","unstructured":"Roh, Y. S., Zhang, B., Loomba, R. & Seki, E. TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration. Am. J. Physiol.-Gastrointest. Liver Physiol. 309, G30-G41 (2015).","DOI":"10.1152\/ajpgi.00031.2015"},{"key":"6414_CR50","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jhep.2018.07.005","volume":"69","author":"TN Bukong","year":"2018","unstructured":"Bukong, T. N. et al. Abnormal neutrophil traps and impaired efferocytosis contribute to liver injury and sepsis severity after binge alcohol use. J. Hepatol. 69, 1145\u20131154 (2018).","journal-title":"J. Hepatol."},{"key":"6414_CR51","doi-asserted-by":"crossref","unstructured":"Keshavarz Azizi Raftar, S. et al. The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD\/CCl4-Induced Liver Injury. Microbiology Spectrum 9, e00484\u201300421 (2021).","DOI":"10.1128\/Spectrum.00484-21"},{"key":"6414_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-95738-5","volume":"11","author":"F Ashrafian","year":"2021","unstructured":"Ashrafian, F. et al. Comparative effects of alive and pasteurized Akkermansia muciniphila on normal diet-fed mice. Sci. Rep. 11, 1\u201313 (2021).","journal-title":"Sci. Rep."},{"key":"6414_CR53","doi-asserted-by":"crossref","unstructured":"Miura, K. et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1\u03b2 in mice. Gastroenterology 139, 323\u2013334. e327 (2010).","DOI":"10.1053\/j.gastro.2010.03.052"},{"key":"6414_CR54","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ajpath.2019.11.012","volume":"190","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z. et al. Toll-Like Receptor 5 Signaling Ameliorates Liver Fibrosis by Inducing Interferon \u03b2\u2013Modulated IL-1 Receptor Antagonist in Mice. Am. J. Pathol. 190, 614\u2013629 (2020).","journal-title":"Am. J. Pathol."},{"key":"6414_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbrc.2016.01.119","volume":"471","author":"M Shu","year":"2016","unstructured":"Shu, M., Huang, D.-D., Hung, Z.-A., Hu, X.-R. & Zhang, S. Inhibition of MAPK and NF-\u03baB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice. Biochem. Biophys. Res. Commun. 471, 233\u2013239 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"6414_CR56","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/liv.12315","volume":"34","author":"V Kesar","year":"2014","unstructured":"Kesar, V. & Odin, J. A. Toll-like receptors and liver disease. Liver Int. 34, 184\u2013196 (2014).","journal-title":"Liver Int."},{"key":"6414_CR57","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","volume":"64","author":"D Schmidt-Arras","year":"2016","unstructured":"Schmidt-Arras, D. & Rose-John, S. IL-6 pathway in the liver: From physiopathology to therapy. J. Hepatol. 64, 1403\u20131415 (2016).","journal-title":"J. Hepatol."},{"key":"6414_CR58","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1080\/21645515.2020.1761203","volume":"16","author":"AA Widjaja","year":"2020","unstructured":"Widjaja, A. A., Chothani, S. P. & Cook, S. A. Different roles of interleukin 6 and interleukin 11 in the liver: Implications for therapy. Hum. Vaccin. Immunother. 16, 2357\u20132362 (2020).","journal-title":"Hum. Vaccin. Immunother."},{"key":"6414_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-021-00738-1","volume":"21","author":"B Ayelign","year":"2021","unstructured":"Ayelign, B. et al. Association of IL-10 (\u2212 1082 A\/G) and IL-6 (\u2212 174 G\/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population. BMC Endocr. Disord. 21, 1\u20138 (2021).","journal-title":"BMC Endocr. Disord."},{"key":"6414_CR60","doi-asserted-by":"publisher","first-page":"10751","DOI":"10.1096\/fj.201902476R","volume":"34","author":"X Wan","year":"2020","unstructured":"Wan, X. et al. PGC1\u03b1 protects against hepatic steatosis and insulin resistance via enhancing IL10-mediated anti-inflammatory response. FASEB J. 34, 10751\u201310761 (2020).","journal-title":"FASEB J."},{"key":"6414_CR61","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jhep.2011.04.007","volume":"55","author":"H Tilg","year":"2011","unstructured":"Tilg, H. & Moschen, A. R. IL-1 cytokine family members and NAFLD: neglected in metabolic liver inflammation. J. Hepatol. 55, 960\u2013962 (2011).","journal-title":"J. Hepatol."},{"key":"6414_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.livres.2018.03.003","volume":"2","author":"L Niederreiter","year":"2018","unstructured":"Niederreiter, L. & Tilg, H. Cytokines and fatty liver diseases. Liver Research 2, 14\u201320 (2018).","journal-title":"Liver Research"},{"key":"6414_CR63","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12602-020-09663-6","volume":"13","author":"C Jantararussamee","year":"2021","unstructured":"Jantararussamee, C., Rodniem, S., Taweechotipatr, M., Showpittapornchai, U. & Pradidarcheep, W. Hepatoprotective effect of probiotic lactic acid bacteria on thioacetamide-induced liver fibrosis in rats. Probiot. Antimicrob. Prot. 13, 40\u201350 (2021).","journal-title":"Probiot. Antimicrob. Prot."},{"key":"6414_CR64","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/jcpe.13214","volume":"47","author":"O Huck","year":"2020","unstructured":"Huck, O. et al. Akkermansia muciniphila reduces Porphyromonas gingivalis-induced inflammation and periodontal bone destruction. J. Clin. Periodontol. 47, 202\u2013212 (2020).","journal-title":"J. Clin. Periodontol."},{"key":"6414_CR65","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2119\/molmed.2010.00108","volume":"17","author":"AR Moschen","year":"2011","unstructured":"Moschen, A. R. et al. Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol. Med. 17, 840\u2013845 (2011).","journal-title":"Mol. Med."},{"key":"6414_CR66","doi-asserted-by":"crossref","unstructured":"Nov, O. et al. Interleukin-1\u03b2 regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability. PloS one 8, e53626 (2013).","DOI":"10.1371\/journal.pone.0053626"},{"key":"6414_CR67","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pharmthera.2017.05.011","volume":"179","author":"N Tanaka","year":"2017","unstructured":"Tanaka, N., Aoyama, T., Kimura, S. & Gonzalez, F. J. Targeting nuclear receptors for the treatment of fatty liver disease. Pharmacol. Ther. 179, 142\u2013157 (2017).","journal-title":"Pharmacol. Ther."},{"key":"6414_CR68","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1146\/annurev-pharmtox-010715-103209","volume":"56","author":"S Rudraiah","year":"2016","unstructured":"Rudraiah, S., Zhang, X. & Wang, L. Nuclear receptors as therapeutic targets in liver disease: are we there yet?. Annu. Rev. Pharmacol. Toxicol. 56, 605\u2013626 (2016).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"6414_CR69","doi-asserted-by":"crossref","unstructured":"Wu, L. et al. Crosstalk between PPARs and gut microbiota in NAFLD. Biomed. Pharmacother. 136, 111255 (2021).","DOI":"10.1016\/j.biopha.2021.111255"},{"key":"6414_CR70","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/cells8121544","volume":"8","author":"JH Choi","year":"2019","unstructured":"Choi, J. H. et al. Platyconic acid A, platycodi radix-derived saponin, suppresses TGF-\u03b21-induced activation of hepatic stellate cells via blocking SMAD and activating the PPAR\u03b3 signaling pathway. Cells 8, 1544 (2019).","journal-title":"Cells"},{"key":"6414_CR71","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1021\/acs.jafc.5b05827","volume":"64","author":"F Nakamura","year":"2016","unstructured":"Nakamura, F. et al. Fragmented lactic Acid bacterial cells activate peroxisome proliferator-activated receptors and ameliorate Dyslipidemia in obese mice. J. Agric. Food Chem. 64, 2549\u20132559 (2016).","journal-title":"J. Agric. Food Chem."},{"key":"6414_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.livres.2020.03.001","volume":"4","author":"X Yang","year":"2020","unstructured":"Yang, X., Gonzalez, F. J., Huang, M. & Bi, H. Nuclear receptors and non-alcoholic fatty liver disease: An update. Liver Research 4, 88\u201393 (2020).","journal-title":"Liver Research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06414-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06414-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06414-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:45:17Z","timestamp":1669329917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06414-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6414"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-06414-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2453"}}